Risk-conferring HLA variants in an epilepsy cohort: benefits of multifaceted use of whole genome sequencing in clinical practice
Angeliki Vakrinou, Ravishankara Bellampalli, Medine I Gulcebi, et al.
Genomic medicine is already helping more people receive answers about their health conditions through better diagnosis, treatment, and support. By volunteering to take part in research, you'll be making a difference to NHS patients and the future of genomic medicine.
The Predisposition and Screening community will analyse genome data from families and individuals in the NGRL, including participants in the Generation Study and Diverse Data initiative, to identify de novo and inherited variants causing or predisposing to disease in diverse ancestries.
Professor Elijah Behr
St George's University
Professor Sanjay Sisodiya
University College London
The Predisposition and Screening community will analyse genome data from families and individuals in the NGRL, including participants in the Generation Study and Diverse Data initiative, to identify de novo and inherited variants causing or predisposing to disease in diverse ancestries.
Professor Elijah Behr
St George's University
Professor Sanjay Sisodiya
University College London
The impact of collecting and using patient data isn't always straightforward, so we're always listening to public opinion and leading the ethics debate.
Watch this short video on the public dialogue around screening the whole genomes of newborns.
The NHS Genomic Medicine Service (GMS) Research Collaborative is a partnership between the NHS GMS, Genomics England and the National Institute of Health Research (NIHR) to support genomic research and development on a national scale.
Angeliki Vakrinou, Ravishankara Bellampalli, Medine I Gulcebi, et al.
Zoe Crane-Smith, Sandra C P De Castro, Evanthia Nikolopoulou, et al.
Menelaos Pipis, Seongsik Won, Roy Poh, et al.